Publicacións en colaboración con investigadores/as de Pfizer (United States) (3)

2017

  1. Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in spain

    ClinicoEconomics and Outcomes Research, Vol. 9, pp. 39-47

2011

  1. Prophylaxis therapy in haemophilia A: Current situation in Spain

    Haemophilia, Vol. 17, Núm. 1, pp. 75-80

1996

  1. Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis

    Thrombosis and Haemostasis, Vol. 76, Núm. 2, pp. 195-199